Interleukin-6 upregulates neuronal adenosine A1 receptors: implications for neuromodulation and neuroprotection. (Q46911641)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17987062%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Interleukin-6 upregulates neuronal adenosine A1 receptors: implications for neuromodulation and neuroprotection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17987062%20AND%20SRC:MED&resulttype=core&format=json

Erratum: Interleukin-6 Upregulates Neuronal Adenosine A1 Receptors: Implications for Neuromodulation and Neuroprotection

9 January 2020

corrigendum / erratum

1 reference

12 July 2019

http://api.crossref.org/works?select=update-to&filter=doi:10.1038/NPP.2008.92

author

Adriaan P IJzerman

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17987062%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Joaquim A. Ribeiro

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17987062%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Ulrich Eisel

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17987062%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Ana Sebastião

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17987062%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

António Pinto-Duarte

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17987062%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Amalia Dolga

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17987062%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Knut Biber

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17987062%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

M C Wittendorp

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17987062%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

C C Fernandes

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17987062%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

J Von Frijtag Drabbe Künzel

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17987062%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

J N Keijser

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17987062%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

R de Vries

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17987062%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

H W G M Boddeke

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17987062%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

language of work or name

English

0 references

publication date

7 November 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17987062%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

published in

Neuropsychopharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17987062%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17987062%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

2237-2250

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17987062%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17987062%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301612

9 January 2020

exact match

0 references

cites work

Prolonged in vitro exposure of rat brain slices to adenosine analogues: selective desensitization of adenosine A1 but not A2 receptors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

The LTP Program: a data acquisition program for on-line analysis of long-term potentiation and other synaptic events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Capabilities of the WinLTP data acquisition program extending beyond basic LTP experimental functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Changes in seizure latency correlate with alterations in A1 adenosine receptor binding during daily repeated pentylentetrazol-induced convulsions in different mouse brain areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Deletion of presynaptic adenosine A1 receptors impairs the recovery of synaptic transmission after hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Effects of repeated injection of cyclosporin A on pentylenetetrazol-induced convulsion and cyclophilin mRNA levels in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Adenosine A1 receptor inhibition of glutamate exocytosis and protein kinase C-mediated decoupling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Neuroprotective effect of interleukin-6 and IL6/IL6R chimera in the quinolinic acid rat model of Huntington's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Interleukin-6 enhances expression of adenosine A(1) receptor mRNA and signaling in cultured rat cortical astrocytes and brain slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Increased vulnerability of dopaminergic neurons in MPTP-lesioned interleukin-6 deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Interleukin-6 produces neuronal loss in developing cerebellar granule neuron cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Adenosine A(1) receptor: analysis of the potential therapeutic effects obtained by its activation in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Vesicle-mediated transport and release of CCL21 in endangered neurons: a possible explanation for microglia activation remote from a primary lesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Susceptibility to audiogenic seizure and neurotransmitter amino acid levels in different brain areas of IL-6-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Seizure susceptibility to various convulsant stimuli of knockout interleukin-6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Activation of adenosine A2A receptor facilitates brain-derived neurotrophic factor modulation of synaptic transmission in hippocampal slices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Purinergic mechanisms in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

The role and regulation of adenosine in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Interleukin-6 (IL-6)--a molecule with both beneficial and destructive potentials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Seizure suppression by adenosine A1 receptor activation in a mouse model of pharmacoresistant epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Physiological and pathological roles of interleukin-6 in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Regulation of body temperature and neuroprotection by endogenous interleukin-6 in cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Differential regulation of cytokine expression following pilocarpine-induced seizure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

The pentylenetetrazole-kindling model of epilepsy in SAMP8 mice: behavior and metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Adenosine in the central nervous system: release mechanisms and extracellular concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Expression of cytokines and cytokine receptors in the rat brain after kainic acid-induced seizures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Regulation of IL-6 system in cerebrospinal fluid and serum compartments by seizures: the effect of seizure type and duration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Adenosine by activating A1 receptors prevents GABAA-mediated actions during hypoxia in the rat hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Interaction of barbiturates with adenosine receptors in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-D-aspartate receptor activation. Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-kappa B pat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Chronic interleukin-6 exposure alters metabotropic glutamate receptor-activated calcium signalling in cerebellar Purkinje neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Indicators of inflammation after recent tonic-clonic epileptic seizures correlate with plasma interleukin-6 levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Interleukin-6 deficiency reduces the brain inflammatory response and increases oxidative stress and neurodegeneration after kainic acid-induced seizures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Adenosine A2A receptors control the extracellular levels of adenosine through modulation of nucleoside transporters activity in the rat hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Prevention of neuron and oligodendrocyte degeneration by interleukin-6 (IL-6) and IL-6 receptor/IL-6 fusion protein in organotypic hippocampal slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

What can adenosine neuromodulation do for neuroprotection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Desensitization and internalization of adenosine A1 receptors in rat brain by in vivo treatment with R-PIA: involvement of coated vesicles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Profound increase in sensitivity to glutamatergic- but not cholinergic agonist-induced seizures in transgenic mice with astrocyte production of IL-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Adaptation of adult brain tissue to anoxia and hypoxia in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Adenosine-induced expression of interleukin-6 in astrocytes through protein kinase A and NF-IL-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Modification of adenosine modulation of synaptic transmission in the hippocampus of aged rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

The inhibitory adenosine receptor at the neuromuscular junction and hippocampus of the rat: antagonism by 1,3,8-substituted xanthines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Interleukin-6 promotes post-traumatic healing in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Adenosine-activated potassium conductance in cultured striatal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Reduced density of adenosine A1 receptors and preserved coupling of adenosine A1 receptors to G proteins in Alzheimer hippocampus: a quantitative autoradiographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Seizure activity produces differential changes in adenosine A1 receptors within rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Interleukin-6 expression and regulation in astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

The mouse brain adenosine A1 receptor: functional expression and pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Adenosine receptor agonists: from basic medicinal chemistry to clinical development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Purines and neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

Ischemia-Induced Interleukin-6 as a Potential Endogenous Neuroprotective Cytokine against NMDA Receptor-Mediated Excitoxicity in the Brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

7 January 2021

Upregulation of A1 adenosine receptors in human temporal lobe epilepsy: a quantitative autoradiographic study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

7 January 2021

Adenosine A1 receptor-mediated activation of phospholipase C in cultured astrocytes depends on the level of receptor expression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

7 January 2021

Interleukin-6 inhibits neurotransmitter release and the spread of excitation in the rat cerebral cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

7 January 2021

Inhibition of NMDA receptor-mediated currents in isolated rat hippocampal neurones by adenosine A1 receptor activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

7 January 2021

GABAB and adenosine receptors mediate enhancement of the K+ current, IAHP, by reducing adenylyl cyclase activity in rat CA3 hippocampal neurons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

7 January 2021

Adenosine depresses excitatory but not fast inhibitory synaptic transmission in area CA1 of the rat hippocampus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

7 January 2021

Differential localization of adenosine A1 receptors in the rat hippocampus: quantitative autoradiographic study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

7 January 2021

Effect of pentylentetrazol-induced seizures on A1 adenosine receptor regional density in the mouse brain: a quantitative autoradiographic study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

7 January 2021

Elevated levels of interleukin-6 may occur in cerebrospinal fluid from patients with recent epileptic seizures

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

7 January 2021

Interleukin-6 and interleukin-1 receptor antagonist in cerebrospinal fluid from patients with recent tonic-clonic seizures

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

7 January 2021

Chronic interleukin-6 alters NMDA receptor-mediated membrane responses and enhances neurotoxicity in developing CNS neurons.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

7 January 2021

Stimulation of interleukin-6 secretion and gene transcription in primary astrocytes by adenosine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

7 January 2021

Activation of synaptic NMDA receptors by action potential-dependent release of transmitter during hypoxia impairs recovery of synaptic transmission on reoxygenation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

7 January 2021

Resting and active properties of pyramidal neurons in subiculum and CA1 of rat hippocampus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

7 January 2021

Adenosine A1 receptors are located predominantly on axons in the rat hippocampal formation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

7 January 2021

Adenosine inhibits excitatory but not inhibitory synaptic transmission in the hippocampus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301612

7 January 2021